B
Bestzyme
GenScript-backed industrial enzymes for feed, food and biocatalysis
About Bestzyme
Bestzyme Enzyme Engineering specializes in the research, development, and manufacturing of enzyme products, serving industries such as food, beverage, bioethanol, and animal feed. The company operates in the biotechnology market, focusing on enzyme engineering to meet the specific needs of its diverse clientele. Bestzyme leverages the advanced gene synthesis and protein engineering capabilities of its parent company, Genscript, to innovate and produce high-quality enzyme solutions. The business model revolves around providing tailored enzyme products that enhance the efficiency and quality of its clients' operations. Revenue is generated through the sale of these specialized enzyme products and solutions. Bestzyme's commitment to continuous innovation and quality has positioned it as a leading enzyme manufacturer in China, with a global reach. The company collaborates closely with industry partners to develop solutions that address daily challenges and improve overall productivity.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Jinan, China
- Employees
- 4
- Open positions
- 1
- Dealroom signal
- 24.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | May 2023 | $34M | $138M | Huatai Zijin Investment · Jiangsu Jibai Investment Management · Invent Investment · Daoxing Investment | ↗ |
Growth signals
Latest recorded traffic for Bestzyme is 1K monthly website visits, up 194.1% over the last three months. Bestzyme's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later7 investors entered at this stage
Huatai Zijin Investment- JMJiangsu Jibai Investment Management
- IIInvent Investment
- DIDaoxing Investment
- HXHainan Xuanwan
- NLNanjing Lixu
- HHHainan Haiying
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bestzyme on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bestzyme’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






